عناصر مشابهة

Impact of Marketing Costs and the Research and Development on the Profitability of Egypt's Pharmaceutical Companies

تفصيل البيانات البيبلوغرافية
المصدر:المجلة العلمية للدراسات المحاسبية
الناشر: جامعة قناة السويس - كلية التجارة
المؤلف الرئيسي: Abdo, Bassant Badr Eldin (مؤلف)
مؤلفين آخرين: Abouzeid, Walid Aboubakr (Co-Author)
المجلد/العدد:مج1, ع2
محكمة:نعم
الدولة:مصر
التاريخ الميلادي:2019
الصفحات:40 - 67
ISSN:2636-3739
رقم MD:1098795
نوع المحتوى: بحوث ومقالات
اللغة:English
قواعد المعلومات:EcoLink
مواضيع:
رابط المحتوى:
الوصف
المستخلص:The main objective of this study is to examine the impact of marketing and R&D expenditures on the competitiveness of Egypt's pharmaceutical companies. In this report, Egypt Stock Exchange admitted pharmaceutical companies. Data estimator random-effect panel was used for this purpose. The results indicate that variables such as the size of a business, the capital-to-total ratio of assets and the debt-to-asset ratio affect profitability. Nonetheless, on competitiveness, business life, advertisement costs and spending in R&D are unsuccessful. Legal concerns such as the absence of patent law and the framework for pricing are reasons for the poor partnership between R&D and marketing costs and its effect on income, The results indicate that variables such as the size of a business, the capital--ratio of assets and the debt--ratio affect profitability. Nonetheless, on competitiveness, business life, advertisement costs and spending in R&D are unsuccessful. Regulatory problems including the lack of & absence of patent law and pricing controls are reasons for the poor partnership between R&D and marketing costs and its impact on the Egyptian pharmaceutical industry's profitability